Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Relapsed Small Cell Lung Cancer
NCT00216216Phase 2Terminated
- Sponsor
- Hoosier Cancer Research Network
- Start
- Jan 2005
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in small cell lung cancer (SCLC), sponsored by Hoosier Cancer Research Network. Started Jan 2005; status: terminated.
02
Drugs
pemetrexed
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00216216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216216.